BENSON CHIN: Open Payments
NPI 1134218266 · YUBA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,765 in 95 payments from 22 companies in 2025. Trend: 2023 $2,626 · 2024 $1,716 · 2025 $1,765
Food & beverage: $1,765
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 38 | $527 |
| AstraZeneca Pharmaceuticals LP | 7 | $178 |
| ABBVIE INC. | 13 | $161 |
| Viatris Specialty LLC | 5 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $95 |
| Daiichi Sankyo Inc. | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 1 | $69 |
| Novo Nordisk Inc | 3 | $67 |
| Optinose US, Inc. | 3 | $60 |
Products named: EVENITY, YUPELRI, BREZTRI, TRINTELLIX, REXULTI, QULIPTA, INJECTAFER, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
